PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
|
238g |
43386-312-14 |
MiraLAX® |
AA |
Laxative |
Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
Fyavolv™ | 0.5mg/0.0025mg |
![]() |
28 x 3 |
68180-827-73 |
FemHRT® |
AB |
Hormone Replacement Therapy |
Fosaprepitant Dimeglumine for Injection | 150mg |
|
5mL single-dose vial |
68180-690-01 |
Emend® |
AP |
Antiemetic |
Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
Fluoxetine Tablets USP | 10mg |
![]() |
30 |
68180-998-01 |
Prozac® |
AB |
Anti-depressant |
Fluoxetine Tablets USP | 60mg |
|
30 |
68180-997-06 |
Fluoxetine Tablets |
AB |
Anti-depressant |
Fluocinonide Topical Solution USP | 0.05% |
![]() |
20 mL |
43386-026-02 |
Lidex® |
AT |
Corticosteroid |
Flucytosine Capsules USP | 250 mg |
|
100 |
43386-771-01 |
Ancobon® |
AB |
Antifungal |
Fenofibrate Tablets | 48mg |
|
90 |
68180-360-09 |
Tricor® |
AB |
Antihyperlipidemic agent |
Fenofibrate Tablets | 54mg |
|
90 |
68180-231-09 |
Lofibra® |
AB |
Antihyperlipidemic agent |
Fenofibrate Capsules | 90mg |
![]() |
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.